Dan S. Zuckerman, MD

Education

Medical School

University of Chicago

Residency

Brigham & Women’s Hospital

Fellowship

Dana-Farber Cancer Institute

Board Certification

• Medical Oncology

• Internal Medicine

• Hematology

Awards and Distinctions

• 2006
  Clinical Fellows Distinguished Excellence in Teaching Award, Dana Farber

  2003
  Dunne Award, Brigham and Women’s Hospital

  2002
  Outstanding Achievement Award in Medicine, University of Chicago Pritzker School of Medicine

  1993
  Valedictorian, Boise High School

Publications

• 2011
  van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann S, Bosserman LD, Geoghegan C, Hillner BE, Theriault RL, Zuckerman DS, von Roenn JH. American Society of Clinical Oncology Clinical Practice Guideline Update on the Role of Bone Modifying Agents in Metastatic Breast Cancer. J Clin Oncol 2011, in press.

  2010
  Lee AI, Zuckerman DS, Van den Abbeele AD, Aquino SL, Crowley D, Toomey C, Lacasce AS, Feng Y, Neuberg DS, Hocberg EP. Surveillance imaging of Hodgkin lymphoma in patients in first remission: a clinical and economic analysis. Cancer. 2010;116:3835-3842.

  2008
  Zuckerman DS, Clark JW. Systemic therapy for metastatic colorectal cancer: current questions. Cancer 2008; 112:1879-1891.

  2008
  Zuckerman DS, Ryan DP. Adjuvant therapy for pancreatic cancer: A review. Cancer 2008;112:243-249.